Cover Image

Hemostatic efficacy of latest-generation fibrin sealant after hepatic resection: a randomized controlled clinical study

This randomized, controlled, single-blinded multicenter study evaluated the efficacy of latest-generation fibrin sealant containing synthetic aprotinin as fibrinolysis inhibitor as supportive treatment for hemostasis after elective partial hepatectomy.

Saved in:
Bibliographic Details
Main Authors: Bektaş, Hüseyin (Author) , Nadalin, Silvio (Author) , Szabo, Ildiko (Author) , Ploder, Bettina (Author) , Sharkhawy, Marlies (Author) , Schmidt, Jan (Author)
Format: Article (Journal)
Language:English
Published: 19 July 2014
In: Langenbeck's archives of surgery
Year: 2014, Volume: 399, Issue: 7, Pages: 837-847
ISSN:1435-2451
DOI:10.1007/s00423-014-1227-1
Online Access:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1007/s00423-014-1227-1
Get full text
Author Notes:Hüseyin Bektas, Silvio Nadalin, Ildiko Szabo, Bettina Ploder, Marlies Sharkhawy, Jan Schmidt
Description
Summary:This randomized, controlled, single-blinded multicenter study evaluated the efficacy of latest-generation fibrin sealant containing synthetic aprotinin as fibrinolysis inhibitor as supportive treatment for hemostasis after elective partial hepatectomy.
Item Description:Gesehen am 09.07.2020
Physical Description:Online Resource
ISSN:1435-2451
DOI:10.1007/s00423-014-1227-1

Similar Items